
Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer
The findings, published in Nature Medicine, show that the vaccine can trigger powerful and lasting immune responses and may help prevent or delay cancer recurrence in high-risk patients whose tumors are driven by KRAS mutations.